mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.1 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.1 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.1 |